Daniel Faga - 26 Nov 2021 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role
Director
Signature
/s/ Eric Loumeau, Attorney-in-Fact
Issuer symbol
ANAB
Transactions as of
26 Nov 2021
Transactions value $
$0
Form type
4
Filing time
30 Nov 2021, 16:26:09 UTC
Next filing
14 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANAB Stock Option (Right to Buy) Award $0 +11K $0.00 11K 26 Nov 2021 Common Stock 11K $31.12 Direct F1
transaction ANAB Stock Option (Right to Buy) Award $0 +2.32K $0.00 2.32K 26 Nov 2021 Common Stock 2.32K $31.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the total shares subject to the option shall vest on December 26, 2021 and 1/36th of the total shares subject to the option shall vest on each monthly anniversary thereafter, subject to the reporting person's continuous status as a director through each such date.
F2 The option shall vest and become exercisable in full on February 10, 2022, subject to the reporting person's continuous status as a director through February 10, 2022.